Cancer incidence and mortality in China, 2014.

Background National Central Cancer Registry of China (NCCRC) updated nationwide cancer statistics using population-based cancer registry data in 2014 collected from all available cancer registries. Methods In 2017, 449 cancer registries submitted cancer registry data in 2014, among which 339 registries' data met the criteria of quality control and were included in analysis. These cancer registries covered 288,243,347 population, accounting for about 21.07% of the national population in 2014. Numbers of nationwide new cancer cases and deaths were estimated using calculated incidence and mortality rates and corresponding national population stratified by area, sex, age group and cancer type. The world Segi's population was applied for age-standardized rates. Results A total of 3,804,000 new cancer cases were diagnosed, the crude incidence rate was 278.07/100,000 (301.67/100,000 in males, 253.29/100,000 in females) and the age-standardized incidence rate by world standard population (ASIRW) was 186.53/100,000. Calculated age-standardized incidence rate was higher in urban areas than in rural areas (191.6/100,000 vs. 179.2/100,000). South China had the highest cancer incidence rate while Southwest China had the lowest incidence rate. Cancer incidence rate was higher in female for population between 20 to 54 years but was higher in male for population younger than 20 years or over 54 years. A total of 2,296,000 cancer deaths were reported, the crude mortality rate was 167.89/100,000 (207.24/100,000 in males, 126.54/100,000 in females) and the age-standardized mortality rate by world standard population (ASMRW) was 106.09/100,000. Calculated age-standardized mortality rate was higher in rural areas than in urban areas (110.3/100,000 vs. 102.5/100,000). East China had the highest cancer mortality rate while North China had the lowest mortality rate. The mortality rate in male was higher than that in female. Common cancer types and major causes of cancer death differed between age group and sex. Conclusions Heavy cancer burden and its disparities between area, sex and age group pose a major challenge to public health in China. Nationwide cancer registry plays a crucial role in cancer prevention and control.

[1]  Jun Ren,et al.  Breast Cancer Challenges and Screening in China: Lessons From Current Registry Data and Population Screening Studies. , 2015, The oncologist.

[2]  C. Murray,et al.  Cigarette smoking prevalence in US counties: 1996-2012 , 2014, Population Health Metrics.

[3]  P. Eastman Annual Report on Status of Cancer from ACS, NCI, CDC, Cancer Registries: Targeted Focus on Latinos Will Likely Improve US Cancer Rates , 2006 .

[4]  Ling Wang,et al.  Comparison of Clinicopathological Features and Treatments between Young (≤40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only Study , 2016, PloS one.

[5]  Zhi-cai Liu,et al.  Esophageal/gastric cancer screening in high-risk populations in Henan Province, China. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[6]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[7]  K McPherson,et al.  Breast cancer—epidemiology, risk factors, and genetics , 1994, BMJ : British Medical Journal.

[8]  Jie He,et al.  Annual report on status of cancer in China, 2011. , 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[9]  Wanqing Chen,et al.  Breast cancer in China. , 2014, The Lancet. Oncology.

[10]  M. Gail,et al.  Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. , 2014, Journal of the National Cancer Institute.

[11]  Jie He,et al.  National cancer incidence and mortality in China, 2012. , 2016, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[12]  Jacques Ferlay,et al.  Cancer incidence in five continents. , 1976, IARC scientific publications.

[13]  V. Moyer Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2014, Annals of Internal Medicine.

[14]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[15]  Jie He,et al.  Annual report on status of cancer in China, 2010. , 2014, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[16]  R. Fitzgerald,et al.  Screening for oesophageal cancer , 2012, Nature Reviews Clinical Oncology.

[17]  J. Waterhouse Cancer incidence in five continents, v.3 , 1976 .

[18]  Jie He,et al.  Cancer incidence and mortality in China, 2013. , 2017, Cancer letters.

[19]  M. Gail,et al.  Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. , 2012, Journal of the National Cancer Institute.

[20]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[21]  Zhi-Feng Chen,et al.  Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic Screening Study of Esophageal Cancer in China. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[23]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[24]  S. Rutherford,et al.  Review of the Cervical Cancer Burden and Population-Based Cervical Cancer Screening in China. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[25]  Y. Qiao,et al.  A Nation-Wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in china , 2011, BMC Cancer.

[26]  Ning Wang,et al.  Cancer survival in China, 2003–2005: A population‐based study , 2015, International journal of cancer.

[27]  Ming-Fang Yen,et al.  Cost-effectiveness Analysis between Primary and Secondary Preventive Strategies for Gastric Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[28]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[29]  L. Fan,et al.  Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China , 2009, Breast Cancer Research and Treatment.

[30]  Chuang Chen,et al.  Characteristics of breast cancer in Central China, literature review and comparison with USA. , 2016, Breast.